Recent Quotes (30 days)

You have no recent quotes
chg | %

Cronos Group Inc  

(Public, CVE:MJN)   Watch this stock  
Find more results for MJN
+0.40 (4.06%)
Jan. 16 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 9.75 - 10.75
52 week 1.58 - 14.83
Open 10.50
Vol / Avg. 2.18M/1.93M
Mkt cap 1.53B
P/E 230.54
Div/yield     -
EPS 0.04
Shares 149.21M
Beta 6.24
Inst. own     -
Nov. 29, 2017
Q3 2017 Cronos Group Inc Earnings Call

Key stats and ratios

Q3 (Sep. '17) 2016
Net profit margin 83.51% -214.74%
Operating margin 77.73% -317.23%
EBITD margin - -703.77%
Return on average assets 6.54% -4.13%
Return on average equity 7.43% -5.24%
CDP Score - -


76 Stafford St Suite 302
+1-416-5040004 (Phone)
+1-416-3616455 (Fax)

Website links


Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada's Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc. and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals. Whistler Medical Marijuana is licensed to produce and sell medical marijuana, as well as cultivate cannabis oil. Hydropothecary is licensed to produce medical marijuana. Abcann Medicinals also has license to produce medical marijuana. With interest in five Licensed Producers and two LP applicants, it is focused on building brand portfolio providing patients with personalized care.

Officers and directors

Michael Ryan Gorenstein President, Chief Executive Officer, Vice Chairman of the Board, Corporate Secretary
William Hilson Chief Financial Officer
Jason Adler Director
Ryan Roebuck Director
Alan Mark Friedman Independent Director
Age: 45
Michael Howard Krestell Independent Director